Associations between Omega-3 Fatty Acid Supplementation and Anti-Inflammatory Effects in Patients with Digestive System Cancer: A Meta-Analysis

References

• Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2015. CA: Cancer J Clin 65, 5–29, 2015.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–386, 2015.
   PubMed Web of Science ®Google Scholar
• Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, et al.: Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 111, 611–616, 2004.
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, and Clarke SJ: Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15, e493–503, 2014.
   PubMed Web of Science ®Google Scholar
• Candido J, and Hagemann T: Cancer-related inflammation. J Clin Immunol 33, 79–84, 2013.
   PubMed Web of Science ®Google Scholar
• Tsoli M, and Robertson G: Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem. Trends Endocrinol Metab: TEM 24, 174–183, 2013.
   PubMed Web of Science ®Google Scholar
• Balkwill F, and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357, 539–545, 2001.
   PubMed Web of Science ®Google Scholar
• Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, and Tergaonkar V: Multifaceted link between cancer and inflammation. Biosci Rep 32, 1–15, 2012.
   PubMed Web of Science ®Google Scholar
• Guo J, Chen S, Chen Y, Li S, and Xu D: Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer. CMAR 10, 315–321, 2018.
   Web of Science ®Google Scholar
• D’Eliseo D, and Velotti F: Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy. J Clin Med 5, 2016. doi:10.3390/jcm5020015
   PubMed Web of Science ®Google Scholar
• Pappalardo G, Almeida A, and Ravasco P: Eicosapentaenoic acid in cancer improves body composition and modulates metabolism. Nutrition (Burbank, Los Angeles County, Calif.) 31, 549–555, 2015.
   PubMed Web of Science ®Google Scholar
• Wendel M, and Heller AR: Anticancer actions of omega-3 fatty acids–current state and future perspectives. Anti-Cancer Agents Med Chem 9, 457–470, 2009.
   PubMed Web of Science ®Google Scholar
• Murphy RA, Mourtzakis M, and Mazurak VC: n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Curr Opin Clin Nutr Metab Care 15, 246–251, 2012.
   PubMed Web of Science ®Google Scholar
• Yu J, Liu L, Zhang Y, Wei J, and Yang F: Effects of omega-3 fatty acids on patients undergoing surgery for gastrointestinal malignancy: a systematic review and meta-analysis. BMC Cancer 17, 271, 2017.
   PubMed Web of Science ®Google Scholar
• Bruera E, Strasser F, Palmer JL, Willey J, Calder K, et al.: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21, 129–134, 2003.
   PubMed Web of Science ®Google Scholar
• Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, et al.: An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22, 2469–2476, 2004.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, et al.: Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24, 3401–3407, 2006.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, et al.: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52, 1479–1486, 2003.
   PubMed Web of Science ®Google Scholar
• Collaboration T C: The Nordic Cochrane Centre 2014.
   Google Scholar
• Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, et al.: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clin Res ed.) 343, d5928, 2011.
   PubMed Web of Science ®Google Scholar
• Higgins Jpt GS: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011], 2011
   Google Scholar
• Cochran WG: The combination of estimates from different experiments. Biometrics 10, 101–129, 1954.
   Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, and Altman DG: Measuring inconsistency in meta-analyses. BMJ (Clin Res ed.) 327, 557–560, 2003.
   PubMed Web of Science ®Google Scholar
• de Miranda Torrinhas RS, Santana R, Garcia T, Cury-Boaventura MF, Sales MM, et al.: Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. Clin Nutr (Edinburgh, Scotland) 32, 503–510, 2013.
   PubMed Web of Science ®Google Scholar
• Jiang ZM, Wilmore DW, Wang XR, Wei JM, Zhang ZT, et al.: Randomized clinical trial of intravenous soybean oil alone versus soybean oil plus fish oil emulsion after gastrointestinal cancer surgery. Br J Surg 97, 804–809, 2010.
   PubMed Web of Science ®Google Scholar
• Liang B, Wang S, Ye YJ, Yang XD, Wang YL, et al.: Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 14, 2434–2439, 2008.
   PubMed Web of Science ®Google Scholar
• Ma CJ, Wu JM, Tsai HL, Huang CW, Lu CY, et al.: Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients. Nutr J 14, 9, 2015.
   PubMed Web of Science ®Google Scholar
• Miyata H, Yano M, Yasuda T, Yamasaki M, Murakami K, et al.: Randomized study of the clinical effects of omega-3 fatty acid-containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Nutrition (Burbank, Los Angeles County, Calif.) 33, 204–210, 2017.
   PubMed Web of Science ®Google Scholar
• Mocellin MC, Pastore e Silva J. d A, Camargo C. d Q, Fabre M. E d S, Gevaerd S, et al.: Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 48, 879–888, 2013.
   PubMed Web of Science ®Google Scholar
• Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, et al.: Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 249, 355–363, 2009.
   PubMed Web of Science ®Google Scholar
• Silva JdAP, Trindade EBSdM, Fabre MEdS, Menegotto VM, Ge vaerd S, et al.: Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 64, 267–273, 2012.
   PubMed Web of Science ®Google Scholar
• Sultan J, Griffin SM, Di Franco F, Kirby JA, Shenton BK, et al.: Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99, 346–355, 2012.
   PubMed Web of Science ®Google Scholar
• Wei Z, Wang W, Chen J, Yang D, Yan R, et al.: A prospective, randomized, controlled study of ω-3 fish oil fat emulsion-based parenteral nutrition for patients following surgical resection of gastric tumors. Nutr J 13, 25, 2014.
   PubMed Web of Science ®Google Scholar
• Salem N, Jr., and Eggersdorfer M: Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Curr Opin Clin Nutr Metab Care 18, 147–154, 2015.
   PubMed Web of Science ®Google Scholar
• Laviano A, Rianda S, Molfino A, and Rossi Fanelli F: Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care 16, 156–161, 2013.
   PubMed Web of Science ®Google Scholar
• Virtanen JK, Nyantika AN, Kauhanen J, Voutilainen S, and Tuomainen TP: Serum long-chain n-3 polyunsaturated fatty acids, methylmercury and blood pressure in an older population. Hypertens Res 35, 1000–1004, 2012.
   PubMed Web of Science ®Google Scholar
• Hidayat K, Yang J, Zhang Z, Chen GC, Qin LQ, et al.: Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 72, 805–817, 2018.
   PubMed Web of Science ®Google Scholar
• Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, et al.: Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 112, 56–67, 1992.
   PubMed Web of Science ®Google Scholar
• Balkwill F: Tumour necrosis factor and cancer. Nat Rev Cancer 9, 361–371, 2009.
   PubMed Web of Science ®Google Scholar
• Ries A, Trottenberg P, Elsner F, Stiel S, Haugen D, et al. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med 26, 294–304, 2012.
   PubMed Web of Science ®Google Scholar
• Abunnaja S, Cuviello A, and Sanchez JA: Enteral and parenteral nutrition in the perioperative period: state of the art. Nutrients 5, 608–623, 2013.
   PubMed Web of Science ®Google Scholar
• Zaloga GP: Parenteral nutrition in adult inpatients with functioning gastrointestinal tracts: assessment of outcomes. Lancet (London, England) 367, 1101–1111, 2006.
   PubMed Web of Science ®Google Scholar
• Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, et al.: Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition (Burbank, Los Angeles County, Calif.) 20, 843–848, 2004.
   PubMed Web of Science ®Google Scholar
• Calder PC: Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 45, 1105–1115, 2017.
   PubMed Web of Science ®Google Scholar
• Calder PC: Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851, 469–484, 2015.
   PubMed Web of Science ®Google Scholar
• Dasilva G, Pazos M, Garcia-Egido E, Perez-Jimenez J, Torres JL, et al.: Lipidomics to analyze the influence of diets with different EPA:DHA ratios in the progression of Metabolic Syndrome using SHROB rats as a model. Food Chem 205, 196–203, 2016.
   PubMed Web of Science ®Google Scholar
• Allaire J, Couture P, Leclerc M, Charest A, Marin J, et al.: A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study. Am J Clin Nutr 104, 280–287, 2016.
   PubMed Web of Science ®Google Scholar
• Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, et al.: Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139, 804s–819s, 2009.
   PubMed Web of Science ®Google Scholar